Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4 Reasons To Buy AcelRx Pharmaceuticals
Seeking Alpha
Monday, July 30, 2012 - 10:24am
tags:
AcelRx
Pfizer Earnings Preview: A Pharma Giant Descends From Growth To Value Status
Seeking Alpha
Monday, July 30, 2012 - 10:23am
tags:
earnings, Pfizer
Acura Pharma's Earnings Rescheduled For Monday's Close, With Tuesday Conference Call
Seeking Alpha
Sunday, July 29, 2012 - 1:18pm
tags:
Acura Pharmaceuticals, earnings
Investment Insider: Pharmaceutical industry's best years lie ahead
Independent, UK
Sunday, July 29, 2012 - 1:18pm
tags:
Major Insider Buying And Diversified Pipeline Has Me Interested In This Speculative Drug Stock
Seeking Alpha
Sunday, July 29, 2012 - 1:16pm
tags:
Furiex Pharmaceuticals
Lupin looks to acquire brands in the US; eyes 20% growth
Economic Times, India
Sunday, July 29, 2012 - 1:15pm
tags:
Lupin
Angiotech Pharmaceuticals, Inc. Amends Exchange Offer and Consent Solicitation for its Senior Floating Rate Notes Due 2013
Sacramento Bee, CA
Sunday, July 29, 2012 - 1:14pm
tags:
Angiotech
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
NASDAQ
Sunday, July 29, 2012 - 1:03pm
tags:
Furiex Pharmaceuticals, Takeda, alogliptin, diabetes, type 2 diabetes
Pfizer Terminates License Agreement With Acura For 3 Development Stage Products
RTT News
Sunday, July 29, 2012 - 1:02pm
tags:
Aversion Technology
Biotechs In Motion As New Drug Pipeline Brims
investors.com
Sunday, July 29, 2012 - 1:00pm
tags:
Amgen, Celgene, Biogen Idec, Gilead Sciences, Regeneron, Vertex Pharmaceuticals, Alexion, Arena Pharmaceuticals, ONYX Pharmaceuticals, United Therapeutics
Mylan Launches Generic Version of Sporanox® Capsules By Mylan Inc.
Sacramento Bee, CA
Sunday, July 29, 2012 - 12:58pm
tags:
Mylan, Sporanox, generics, Janssen, blatsomycosis, histoplasmosis, aspergillosis
Dendreon Earnings Approach
Wall Street Cheat Street
Sunday, July 29, 2012 - 12:27pm
tags:
Dendreon, earnings
Hyperion Therapeutics Goes Public
Seeking Alpha
Sunday, July 29, 2012 - 12:22pm
tags:
Hyperion Therapeutics
Buy, Sell, or Hold: Amarin
Motley Fool
Sunday, July 29, 2012 - 12:14pm
tags:
Amarin
A Closer Look At Repros Therapeutics
Seeking Alpha
Sunday, July 29, 2012 - 12:14pm
tags:
Repros Therapeutics
What is Holding Back JNJ from Pulling Up?
Motley Fool
Sunday, July 29, 2012 - 12:13pm
tags:
JNJ
Is This the End of MannKind?
Motley Fool
Sunday, July 29, 2012 - 12:12pm
tags:
MannKind
IBM's Reinvention Should Inspire Flat Pharma Businesses
Forbes
Sunday, July 29, 2012 - 12:11pm
tags:
Bio Buyouts
Motley Fool
Sunday, July 29, 2012 - 12:10pm
tags:
Seattle Genetics, Alexion, Regeneron, Biomarin, Vertex Pharmaceuticals, Idenix, Obagi Medical Products
Why the Shorts Are Attacking VIVUS
Motley Fool
Saturday, July 28, 2012 - 11:46am
tags:
Vivus, Qsymia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.